<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1885-642X</journal-id>
<journal-title><![CDATA[Pharmacy Practice (Granada)]]></journal-title>
<abbrev-journal-title><![CDATA[Pharmacy Pract (Granada)]]></abbrev-journal-title>
<issn>1885-642X</issn>
<publisher>
<publisher-name><![CDATA[Centro de Investigaciones y Publicaciones Farmacéuticas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1885-642X2020000100004</article-id>
<article-id pub-id-type="doi">10.18549/pharmpract.2020.1.1682</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Differences between pharmacists&#8217; perception of counseling and practice in the era of prescription drug misuse]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Thornton]]></surname>
<given-names><![CDATA[J Douglas]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Anyanwu]]></surname>
<given-names><![CDATA[Precious]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Tata]]></surname>
<given-names><![CDATA[Vaishnavi]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Al Rawwad]]></surname>
<given-names><![CDATA[Tamara]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[Marc L]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,University of Houston College of Pharmacy Department of Pharmaceutical Health Outcomes and Policy]]></institution>
<addr-line><![CDATA[Houston TX]]></addr-line>
<country>United States</country>
</aff>
<aff id="A02">
<institution><![CDATA[,University of Houston College of Pharmacy Department of Pharmaceutical Health Outcomes and Policy]]></institution>
<addr-line><![CDATA[Houston TX]]></addr-line>
<country>United States</country>
</aff>
<aff id="A03">
<institution><![CDATA[,University of Houston College of Pharmacy Department of Pharmaceutical Health Outcomes and Policy]]></institution>
<addr-line><![CDATA[Houston TX]]></addr-line>
<country>United States</country>
</aff>
<aff id="A04">
<institution><![CDATA[,University of Houston College of Pharmacy Department of Pharmaceutical Health Outcomes and Policy]]></institution>
<addr-line><![CDATA[Houston TX]]></addr-line>
<country>United States</country>
</aff>
<aff id="A05">
<institution><![CDATA[,University of North Texas Health Science Center College of Pharmacy Department of Pharmacotherapy]]></institution>
<addr-line><![CDATA[Fort Worth TX]]></addr-line>
<country>United States</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>03</month>
<year>2020</year>
</pub-date>
<volume>18</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S1885-642X2020000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S1885-642X2020000100004&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S1885-642X2020000100004&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective: This study was conducted to assess pharmacists&#8217; practices when counseling patients on their prescription medications, and their preferences for training.  Methods: Five focus group discussions of community pharmacists (n=45, with seven to eleven participants in each group) were conducted in a major metropolitan city in the southern United States. Participants were recruited via email using a list of community pharmacists provided by the Texas State Board of Pharmacy. All focus group discussions were structured using a moderator guide consisting of both discrete and open-ended questions. Qualitative analysis software was used to analyze the data with a thematic analysis approach.  Results: The participants in this study had a high self-efficacy regarding their ability to counsel on both new and opioid prescriptions. Many pharmacists experienced the same barriers to counseling and agreed on the components o counseling. However, the themes that emerged showed that the participants exhibited only a partial understanding of the components of counseling. The themes that emerged in the thematic analysis were perceived confidence and discordant counseling practices, inadequate infrastructure, lack of comprehensive counseling, inconsistent use of the Prescription Drug Monitoring Program (PDMP), and pharmacists&#8217; desired training/assistance.  Conclusions: Community pharmacists are in a unique position to help combat the opioid crisis; however, there has been very little research on the pharmacist-patient interaction in this context. With policy changes, such as the PDMP mandate, going into effect across the country, it is important to capitalize on the potential community pharmacists have in ameliorating the opioid crisis in the United States.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Counseling]]></kwd>
<kwd lng="en"><![CDATA[Prescription Drug Misuse]]></kwd>
<kwd lng="en"><![CDATA[Professional Practice]]></kwd>
<kwd lng="en"><![CDATA[Pharmacies]]></kwd>
<kwd lng="en"><![CDATA[Pharmacists]]></kwd>
<kwd lng="en"><![CDATA[Prescription Drug Monitoring Programs]]></kwd>
<kwd lng="en"><![CDATA[Opioid Epidemic]]></kwd>
<kwd lng="en"><![CDATA[Focus Groups]]></kwd>
<kwd lng="en"><![CDATA[Texas]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="">
<collab>United States Department of Health and Human Services</collab>
<source><![CDATA[What is the US Opioid Epidemic?]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>Centers for Disease Control and Prevention (CDC)</collab>
<source><![CDATA[US Opioid Prescribing Rate Maps]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rudd]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Aleshire]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Zibbell]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Gladden]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Increases in Drug and Opioid Overdose Deaths - United States 2000-2014]]></article-title>
<source><![CDATA[MMWR Morb Mortal Wkly Rep]]></source>
<year>2016</year>
<volume>64</volume>
<numero>50-51</numero>
<issue>50-51</issue>
<page-range>1378-82</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>Substance Abuse and Mental Health Services Administration</collab>
<source><![CDATA[Results from the 2006 National Survey on Drug Use and Health: National Findings National Clearinghouse for Alcohol and Drug Information]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="">
<collab>National Center for Health Statistics</collab>
<source><![CDATA[Drug Poisoning Mortality: United States, 1999-2015. Centers for Disease Control and Prevention. County Estimates- 2015]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="book">
<source><![CDATA[Secretary Price Announces HHS Strategy for Fighting Opioid Crisis]]></source>
<year>2017</year>
<publisher-loc><![CDATA[Atlanta, GA ]]></publisher-loc>
<publisher-name><![CDATA[National Rx Drug Abuse and Heroin Summit]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<collab>Agency for Healthcare Research and Quality</collab>
<source><![CDATA[Special Emphasis Notice (SEN): AHRQ announces interest in health services research to address the opioids crisis]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thornton]]></surname>
<given-names><![CDATA[JD]]></given-names>
</name>
<name>
<surname><![CDATA[Lyvers]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Scott]]></surname>
<given-names><![CDATA[VG]]></given-names>
</name>
<name>
<surname><![CDATA[Dwibedi]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacists'readiness to provide naloxone in community pharmacies in West Virginia]]></article-title>
<source><![CDATA[J Am Pharm Assoc (2003)]]></source>
<year>2017</year>
<volume>57</volume>
<numero>2S</numero>
<issue>2S</issue>
<page-range>S12-8</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[DV]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services]]></article-title>
<source><![CDATA[Can Pharm J (Ott)]]></source>
<year>2014</year>
<volume>147</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>239-47</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anderson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Blenkinsopp]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Armstrong]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Feedback from community pharmacy users on the contribution of community pharmacy to improving the public's health: a systematic review of the peer reviewed and non-peer reviewed literature 1990-2002]]></article-title>
<source><![CDATA[Health Expect]]></source>
<year>2004</year>
<volume>7</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>191-202</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsuyuki]]></surname>
<given-names><![CDATA[RT]]></given-names>
</name>
<name>
<surname><![CDATA[Beahm]]></surname>
<given-names><![CDATA[NP]]></given-names>
</name>
<name>
<surname><![CDATA[Okada]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Al Hamarneh]]></surname>
<given-names><![CDATA[YN]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacists as accessible primary health care providers: Review of the evidence]]></article-title>
<source><![CDATA[Can Pharm J (Ott)]]></source>
<year>2018</year>
<volume>151</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-5</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<collab>Texas State Board of Pharmacy</collab>
<article-title xml:lang=""><![CDATA[Health Professions: pharmacy and pharmacists: general provisions]]></article-title>
<source><![CDATA[State of Texas]]></source>
<year></year>
<volume>Vol 3</volume>
<edition>3th</edition>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Omnibus Budget Reconciliation Act of 1990]]></article-title>
<source><![CDATA[Statutes at Large]]></source>
<year>1990</year>
<numero>104 Stat</numero>
<issue>104 Stat</issue>
<page-range>1388</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<collab>Texas State Board of Pharmacy</collab>
<source><![CDATA[Texas Prescription Monitoring Program]]></source>
<year></year>
<publisher-name><![CDATA[Texas State Board of Pharmacy]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norwood]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Integration of prescription drug monitoring programs (PDMP) in pharmacy practice: Improving clinical decision-making and supporting a pharmacist's professional judgment]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2016</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>257-66</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perrone]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Medication Reconciliation for Controlled Substances &#8212; An &#8220;Ideal&#8221; Prescription-Drug Monitoring Program]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2012</year>
<volume>366</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>2341-3</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goodin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Blumenschein]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Freeman]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
<name>
<surname><![CDATA[Talbert]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Consumer/patient encounters with prescription drug monitoring programs: evidence from a Medicaid population]]></article-title>
<source><![CDATA[Pain Physician]]></source>
<year>2012</year>
<volume>15</volume>
<numero>3 Suppl</numero>
<issue>3 Suppl</issue>
<page-range>ES169-E175</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Norwood]]></surname>
<given-names><![CDATA[CW]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2016</year>
<volume>12</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>509-14</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wixson]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Talbert]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Blumenschein]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Freeman]]></surname>
<given-names><![CDATA[PR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[PHP93 Impact of Prescription Monitoring Programs on Pharmacists'Controlled Substance Dispensing Behavior]]></article-title>
<source><![CDATA[Value Health]]></source>
<year>2012</year>
<volume>15</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>A29-30</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Bapat]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Varisco]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Using the theory of planned behavior to investigate community pharmacists'beliefs regarding engaging patients about prescription drug misuse]]></article-title>
<source><![CDATA[Res Social Adm Pharm]]></source>
<year>2019</year>
<volume>15</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>992-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Braun]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Clarke]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Using thematic analysis in psychology]]></article-title>
<source><![CDATA[Qual Res Psychol]]></source>
<year>2006</year>
<volume>3</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>77-101</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="">
<source><![CDATA[Atlas.ti]]></source>
<year></year>
<edition>Version 7</edition>
<publisher-loc><![CDATA[Berlin, Germany ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hartung]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Haverly]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[Cameron]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Alley]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hildebran]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[O'Kane]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pharmacists'role in opioid safety:a focus group investigation]]></article-title>
<source><![CDATA[Pain Med]]></source>
<year>2018</year>
<volume>19</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1799-806</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Varisco]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fleming]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Bapat]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Wanat]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Thornton]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Health care practitioner counseling encourages disposal of unused opioid medications]]></article-title>
<source><![CDATA[J Am Pharm Assoc (2003)]]></source>
<year>2019</year>
<volume>59</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>809-15</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Pharmacists'role in addressing opioid abuse, addiction, and diversion]]></article-title>
<source><![CDATA[J Am Pharm Assoc (2003)]]></source>
<year>2014</year>
<volume>54</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e5-e15</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<collab>American Society of Health System Pharmacists</collab>
<article-title xml:lang=""><![CDATA[ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance]]></article-title>
<source><![CDATA[Am J Health Syst Pharm]]></source>
<year>2014</year>
<volume>71</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>243-6</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leong]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sareen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Enns]]></surname>
<given-names><![CDATA[MW]]></given-names>
</name>
<name>
<surname><![CDATA[Bolton]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Alessi-Severini]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Community pharmacy practice barriers in preventing drug misuse, divergence and overdose: a focus group study]]></article-title>
<source><![CDATA[Healthc Q]]></source>
<year>2015</year>
<volume>18</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>28-33</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
